Solid oral dosage form comprising a combination ofmetformin and glibenclamide.
FR2840609A1
New nitrosodiphenylamine derivatives useful for treating e.g. restenosis, diabetes, atherosclerosis associated ischemias, restenosis after angioplasty and stenosis after vascular surgery
FR2838968A1
Association of insulin and a thiazolidinedione derivative and use thereof for treating diabetes
FR2836917A1
Nitroso diphenylamine derivatives, pharmaceutical compositions containing same as medicaments for the treatment of diseases characterized by oxidative stress situation
FR2834640A1
Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid and its use for treating diabetes
FR2834214A1
Pharmaceutical composition comprising an alpha-glucosidase inhibitor and 4-oxo-butanoic acid and its use for treating diabetes
FR2832925A1
Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
FR2832930A1
Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative and use thereof for the preparation of medicines for treating diabetes
FR2832927A1
Pharmaceutical composition comprising a 4-oxo-butanoic acid and a thiazolidinedione derivative and use thereof for the preparation of medicaments for the treatment of diabetes
FR2832633A1
Pharmaceutical composition comprising a metformin association and a 4-oxo-butanoic acid and its use for treating diabetes
FR2832064A1
Pharmaceutical composition comprising glitazone and thiazolidinedione derivative and use thereof for the treatment of diabetes
AU1409602A
Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
FR2830862A1
New nitroso diphenylamine derivatives are nitrogen monoxide generating agents, useful for treating pathologies characterized by an oxidative stress condition
FR2829765A1
Use of new and known benzimidazolyl alkoxyaryl alkanoic acid derivatives for treating pathologies associated with insulin resistance or hyperglycemia
FR2829766A1
Composition useful in the treatment of pathologies associated with e.g. hyperglycemia, diabetes, dyslipidemia, obesity, arterial hypertension, neuropathies, and nephropathies, comprises oxamate derivatives
FR2827859A1
4- (arylthio) - or 4- (heteroarylthio) -butyric derivatives in the preparation of medicines for the treatment of diabetes
FR2827862A1
New imidazolyl alkyl aryl alkanoic acid derivatives useful for the treatment of hyperglycemia and related disorders, especially type II diabetes
FR2827600A1
New quinolone acid derivatives with aldose reductase inhibiting activity, useful for prevention and treatment of diabetes-related disorders
FR2826278A1
Use of antidiabetic agents for manufacturing a medicament having a healing effect
FR2822463A1
Bicyclic guanidine derivatives and their therapeutic applications
